Drug intelligence / Profile preview

green-lipped mussel

Development stage
Preclinical
Lead developer
Pharmalink International
Administration
Oral
01

Overview

Green-lipped mussel (GLM), derived from the species *Perna canaliculus* native to New Zealand, is a dietary supplement primarily used to manage inflammatory conditions, most notably osteoarthritis. [2, 5] Its therapeutic effects are attributed to a unique and complex profile of lipids, including various omega-3 polyunsaturated fatty acids (PUFAs) like EPA, DHA, and the rare eicosatetraenoic acid (ETA), as well as furan fatty acids. [3, 6, 21] These compounds are believed to exert anti-inflammatory effects by inhibiting key enzymes in the arachidonic acid cascade, specifically cyclooxygenase (COX) and 5-lipoxygenase (LOX). [3, 13] Clinical studies in humans have demonstrated that GLM extracts can reduce joint pain, stiffness, and improve mobility in patients with knee osteoarthritis. [1, 4] Some research also suggests it may improve gastrointestinal function in these patients, potentially by modulating the gut microbiota. [12] In addition to human use, green-lipped mussel is widely used in veterinary medicine to alleviate symptoms of arthritis in dogs and other animals. [6, 14]

Brand names
LyprinolSeatoneBioLexAntinolPernaTecActivEase
Other names
Perna canaliculusNew Zealand green-lipped musselgreenshell mussel
02

Targets

ADAMTS5 (A disintegrin and metalloproteinase with thrombospondin motifs 5)COX15-LOX (Lysyl Oxidase)MMP3 (Matrix metalloproteinase-3)MMP13 (Matrix metalloproteinase-13)

Beyond the preview

Go deeper on green-lipped mussel.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on green-lipped mussel.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call